Skip to content
Search AI Powered

Latest Stories

Online pharmacies selling prescription-only medicines without 'robust checks'

Some pharmacies were found selling high-risk and potentially addictive medicines, including benzodiazepines and antidepressants, based on online questionnaires

A BBC investigation has found 20 UK online pharmacies selling prescription-only medicines without adhering to the regulatory standards, such as checking for GP approval or patient’s medical records.


The news organisation was able to purchase over 1,600 restricted pills, including anti-anxiety drug, painkiller and sleeping medication, from these regulated online pharmacies easily by providing false information.

However, the report didn’t mention the names of the drugs as “they can be dangerous when taken without medical guidance.”

Some pharmacies were also found selling high-risk and potentially addictive medicines, including benzodiazepines and antidepressants, based on online questionnaires and did not require further checks.

The General Pharmaceutical Council (GPhC), which regulate online pharmacies in the UK, states that selling and supplying medicines at a distance brings "different risks which  need to be appropriately managed to protect patient safety."

GPhC Chief Executive, Duncan Rudkin, said: "The BBC’s undercover investigation raises very serious concerns. We have asked the BBC to provide further information so we can urgently look into these concerns and take action to protect patients and the public.”

“Increasingly people are choosing to access healthcare services online. There can be significant benefits for patients using online services to get medicines and treatment but there are also significant risks that need to be managed to protect patient safety.”

Responding to the BBC’s investigation report, the Royal Pharmaceutical Society (RPS) said: “There is no excuse for poor professional practice or inadequate systems of care in the safe supply of medicines.

“All registered pharmacies, including online services, must safely supply medicines or face robust and appropriate sanctions from the regulators in this space.”

It has asked the three regulatory bodies that are involved in the supervision of online pharmacies, namely the GPhC, the Care Quality Commission and the Medicines and Healthcare Products Regulatory Agency (MHRA), to use their enforcement powers to help eradicate poor professional practice by online providers.

Reacting to this news report, the Pharmacists' Defence Association (PDA) has also reiterated it advice to pharmacists working in online settings, which was issued in July 2022.

It reminded online prescribing pharmacists about the specific risks associated with remote prescribing using a questionnaire-based model, typically with no direct prescriber/patient interaction.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less